Common Stocks (continued)
|
Issuer
| Shares
| Value ($)
|
Radian Group, Inc.
| 107,700
| 2,514,795
|
Southern Missouri Bancorp, Inc.
| 7,900
| 349,180
|
Territorial Bancorp, Inc.
| 9,600
| 250,752
|
TrustCo Bank Corp.
| 37,826
| 1,480,123
|
Washington Federal, Inc.
| 80,352
| 2,678,936
|
WSFS Financial Corp.
| 91,068
| 4,845,728
|
Total
|
| 28,321,425
|
Total Financials
| 245,223,265
|
Health Care 11.9%
|
Biotechnology 4.6%
|
ACADIA Pharmaceuticals, Inc.(a)
| 35,105
| 784,246
|
ADC Therapeutics SA(a)
| 60,935
| 1,319,243
|
Alector, Inc.(a)
| 53,148
| 946,034
|
Alkermes PLC(a)
| 41,525
| 941,372
|
Allogene Therapeutics, Inc.(a)
| 25,392
| 652,574
|
Amicus Therapeutics, Inc.(a)
| 189,085
| 1,750,927
|
Apellis Pharmaceuticals, Inc.(a)
| 17,200
| 968,016
|
Arcutis Biotherapeutics, Inc.(a)
| 19,300
| 508,555
|
Arena Pharmaceuticals, Inc.(a)
| 18,100
| 1,106,091
|
Arrowhead Pharmaceuticals, Inc.(a)
| 42,519
| 3,086,879
|
Atara Biotherapeutics, Inc.(a)
| 107,888
| 1,462,961
|
Avrobio, Inc.(a)
| 75,527
| 678,988
|
Biohaven Pharmaceutical Holding Co., Ltd.(a)
| 33,655
| 2,927,985
|
Blueprint Medicines Corp.(a)
| 29,266
| 2,673,449
|
BridgeBio Pharma, Inc.(a)
| 36,312
| 2,149,670
|
CareDx, Inc.(a)
| 12,650
| 1,017,060
|
Clementia Pharmaceuticals, Inc.(a),(b),(c),(d)
| 134,864
| 0
|
Coherus Biosciences, Inc.(a)
| 166,186
| 2,187,008
|
FibroGen, Inc.(a)
| 41,196
| 875,415
|
G1 Therapeutics, Inc.(a)
| 50,032
| 1,086,695
|
Generation Bio Co.(a)
| 21,546
| 738,166
|
Halozyme Therapeutics, Inc.(a)
| 99,479
| 4,119,425
|
Heron Therapeutics, Inc.(a)
| 83,620
| 1,109,637
|
Intercept Pharmaceuticals, Inc.(a)
| 19,620
| 326,281
|
Iovance Biotherapeutics, Inc.(a)
| 18,000
| 334,260
|
Kronos Bio, Inc.(a)
| 38,034
| 928,410
|
Ligand Pharmaceuticals, Inc.(a)
| 21,123
| 2,486,177
|
Mirati Therapeutics, Inc.(a)
| 8,236
| 1,302,523
|
Natera, Inc.(a)
| 51,490
| 4,847,269
|